Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo

Diabetes

Volumn 59, Issue 6, 2010, Pages 1521-1527

  Paranjape, Sachin A ^a   Chan, Owen ^a   Zhu, Wanling ^a   Horblitt, Adam M ^a   McNay, Ewan C ^b   Cresswell, James A ^a   Bogan, Jonathan S ^a   McCrimmon, Rory J ^a   Sherwin, Robert S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; C PEPTIDE; GLUCAGON; HORMONE RECEPTOR BLOCKING AGENT; INSULIN; INSULIN ANTIBODY; MUSCIMOL; PHLORIZIN; PROTEIN KINASE B; S 691; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EXTRACELLULAR FLUID; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; HORMONE ACTION; INSULIN HYPOGLYCEMIA; MALE; MICROINJECTION; NONHUMAN; PANCREAS SECRETION; PRIORITY JOURNAL; RAT; ZONA INCERTA;

3T3 CELLS; ANIMALS; GLUCAGON; HYPOGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; PANCREAS; PHLORHIZIN; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 77953183468     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0014     Document Type: Article

References (48)

1. Unger RH. The Banting Memorial Lecture 1975: diabetes and the alpha cell. Diabetes 1976;25:136-151
2. Cryer PE. Banting Lecture: hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994;43:1378-1389
3. Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC. Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes 2006;55:1051-1056
4. Banarer S, McGregor VP, Cryer PE. Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 2002;51:958-965 (Pubitemid 34438337)
5. Havel PJ, Taborsky GJ Jr. The contribution of the autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocr Rev 1989;10:332-350
6. Taborsky GJ Jr, Ahrén B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 1998;47:995-1005
7. Sherwin RS. Bringing light to the dark side of insulin: a journey across the blood-brain barrier. Diabetes 2008;57:2259-2268
8. Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell AA. Neuronal glucosensing: what do we know after 50 years? Diabetes 2004;53:2521-2528
9. Kang L, Routh VH, Kuzhikandathil EV, Gaspers LD, Levin BE. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004;53:549-559
10. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995;44:180-184
11. Tong Q, Ye C, McCrimmon RJ, Dhillon H, Choi B, Kramer MD, Yu J, Yang Z, Christiansen LM, Lee CE, Choi CS, Zigman JM, Shulman GI, Sherwin RS, Elmquist JK, Lowell BB. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab 2007;5:383-393
12. Wallum BJ, Taborsky GJ, Jr, Porte D Jr, Figlewicz DP, Jacobson L, Beard JC, Ward WK, Dorsa D. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab 1987;64:190-194
13. Canabal DD, Potian JG, Duran RG, McArdle JJ, Routh VH. Hyperglycemia impairs glucose and insulin regulation of nitric oxide production in glucose-inhibited neurons in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 2007;293:R592-R600
14. Kovacs P, Hajnal A. In vivo electrophysiological effects of insulin in the rat brain. Neuropeptides 2009;43:283-293
15. Cotero VE, Zhang BB, Routh VH. The response of glucose-excited (GE) neurons in the ventromedial hypothalamus (VMH) to decreased glucose is enhanced in a murine model of type 2 diabetes mellitus (T2DM). J Neuroendocrinol 2009 [Epub ahead of print]
16. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002;8:1376-1382
17. Galassetti P, Davis SN. Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia. Clin Sci (Lond) 2000;99:351-362
18. Davis SN, Goldstein RE, Jacobs J, Price L, Wolfe R, Cherrington AD. The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes 1993;42:263-272 (Pubitemid 23045030)
19. Liu D, Moberg E, Kollind M, Lins PE, Adamson U. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man. J Clin Endocrinol Metab 1991;73:1123-1128 (Pubitemid 21901157)
20. Diamond MP, Hallarman L, Starick-Zych K, Jones TW, Connolly-Howard M, Tamborlane WV, Sherwin RS. Suppression of counterregulatory hormone response to hypoglycemia by insulin per se. J Clin Endocrinol Metab 1991;72:1388-1390 (Pubitemid 21921859)
21. Mellman MJ, Davis MR, Shamoon H. Effect of physiological hyperinsulinemia on counterregulatory hormone responses during hypoglycemia in humans. J Clin Endocrinol Metab 1992;75:1293-1297
22. Davis SN, Colburn C, Dobbins R, Nadeau S, Neal D, Williams P, Cherrington AD. Evidence that the brain of the conscious dog is insulin sensitive. J Clin Invest 1995;95:593-602
23. Davis SN, Dunham B, Walmsley K, Shavers C, Neal D, Williams P, Cherrington AD. Brain of the conscious dog is sensitive to physiological changes in circulating insulin. Am J Physiol 1997;272:E567-E575 (Pubitemid 27194693)
24. Fisher SJ, Brüning JC, Lannon S, Kahn CR. Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia. Diabetes 2005;54:1447-1451
25. Ishihara KK, Haywood SC, Daphna-Iken D, Puente EC, Fisher SJ. Brain insulin infusion does not augment the counterregulatory response to hypoglycemia or glucoprivation. Metabolism 2009;58:812-820
26. Chan O, Cheng H, Herzog R, Czyzyk D, Zhu W, Wang A, McCrimmon RJ, Seashore MR, Sherwin RS. Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes 2008;57:1363-1370
27. Yu C, Cresswell J, Löffler MG, Bogan JS. The glucose transporter 4-regulating protein TUG is essential for highly insulin-responsive glucose uptake in 3T3-L1 adipocytes. J Biol Chem 2007;282:7710-7722
28. Schäffer L, Brand CL, Hansen BF, Ribel U, Shaw AC, Slaaby R, Sturis J. A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun 2008;376:380-383
29. Chan O, Zhu W, Ding Y, McCrimmon RJ, Sherwin RS. Blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia. Diabetes 2006;55:1080-1087
30. Kitamura T, Kahn CR, Accili D. Insulin receptor knockout mice. Annu Rev Physiol 2003;65:313-332
31. Plum L, Schubert M, Brüning JC. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 2005;16:59-65
32. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-671 (Pubitemid 30205071)
33. Kawamori D, Kurpad AJ, Hu J, Liew CW, Shih JL, Ford EL, Herrera PL, Polonsky KS, McGuinness OP, Kulkarni RN. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab 2009;9:350-361
34. Cheng H, Zhou L, Zhu W, Wang A, Tang C, Chan O, Sherwin RS, McCrimmon RJ. Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation. Am J Physiol Endocrinol Metab 2007;293:E705-E712
35. Lin HV, Plum L, Ono H, Gutié rrez-Juárez R, Shanabrough M, Borok E, Horvath TL, Rossetti L, Accili D. Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes 2010;59:337-346
36. Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, Barsh GS. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest 2005;115:951-958
37. Rulifson EJ, Kim SK, Nusse R. Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes. Science 2002;296:1118-1120
38. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 2002;5:566-572
39. Bailey SJ, Ravier MA, Rutter GA. Glucose-dependent regulation of gamma-aminobutyric acid (GABA A) receptor expression in mouse pancreatic islet alpha-cells. Diabetes 2007;56:320-327
40. Xu E, Kumar M, Zhang Y, Ju W, Obata T, Zhang N, Liu S, Wendt A, Deng S, Ebina Y, Wheeler MB, Braun M, Wang Q. Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab 2006;3:47-58
41. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, Rossetti L. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005;434:1026-1031
42. McCrimmon RJ, Evans ML, Fan X, McNay EC, Chan O, Ding Y, Zhu W, Gram DX, Sherwin RS. Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 2005;54:3169-3174
43. Yang XJ, Kow LM, Funabashi T, Mobbs CV. Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms. Diabetes 1999;48:1763-1772
44. Kim SK, Rulifson EJ. Conserved mechanisms of glucose sensing and regulation by Drosophila corpora cardiaca cells. Nature 2004;431:316-320
45. Samols E, Bonner-Weir S, Weir GC. Intra-islet insulin-glucagon- somatostatin relationships. Clin Endocrinol Metab 1986;15:33-58
46. Unger RH. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 1985;28:574-578
47. Igawa K, Mugavero M, Shiota M, Neal DW, Cherrington AD. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog. Diabetes 2002;51:3033-3042
48. McCrimmon RJ, Evans ML, Jacob RJ, Fan X, Zhu Y, Shulman GI, Sherwin RS. AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. Am J Physiol Endocrinol Metab 2002;283:E1076-E1083 (Pubitemid 35216968)